Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs used to control blood glucose (sugar) levels in people with type 2 diabetes
Are Mounjaro and Wegovy covered by insurance
Recent research suggests that GLP-1 medications can significantly alter the composition and diversity of gut bacteria
/ Guangzhou Innogen Pharmaceutical Group Co., Ltd., Novo Nordisk A/S, PegBio Co., Ltd., Pfizer Inc., QL Biopharmaceutical Co., Ltd., Roche Holding AG, Sanofi S.A., Sciwind Biosciences Co., Ltd., Tonghua Dongbao Pharmaceutical Co., Ltd., Viking Therapeutics, Inc., Amgen Inc., BioLingus GmbH, D&D Pharmatech Inc., Gmax Biopharm LLC, Hanmi Pharmaceutical Co., Ltd., Vivani Medical, Inc., vTv Therapeutics Inc., Zealand Pharma A/S, Altimmune, Inc., Structure Therapeutics Inc
For a deeper dive, read What Are Collagen Peptides and Their Benefits
Currently, public perception has led to GLP-1s being requested as that solution